Jiang Wenbin has filed 132 insider transactions across 1 company since January 2023.
Most recent transaction: a tax payment of 3825 shares of Cytek Biosciences, Inc. ($CTKB) on March 10, 2026.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 3825 | $4.23 | 5,371,710.0000 | 127,604,317 | 0.07% | 0.00% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 7747 | $4.23 | 5,393,430.0000 | 127,604,317 | 0.14% | 0.01% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 38669 | $0.00 | 5,432,099.0000 | 127,604,317 | 0.72% | 0.03% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 9416 | $4.23 | 5,422,683.0000 | 127,604,317 | 0.17% | 0.01% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 485545 | $0.00 | 485,545.0000 | 127,604,317 | 9999.99% | 0.38% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | A | Restricted Stock Units | 915407 | $0.00 | 915,407.0000 | 127,604,317 | 9999.99% | 0.72% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 15708 | $0.00 | 47,129.0000 | 127,604,317 | 25.00% | 0.01% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 29467 | $0.00 | 176,806.0000 | 127,604,317 | 14.29% | 0.02% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 38669 | $0.00 | 348,030.0000 | 127,604,317 | 10.00% | 0.03% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 15708 | $0.00 | 5,375,535.0000 | 127,604,317 | 0.29% | 0.01% |
| March 10, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 29467 | $0.00 | 5,401,177.0000 | 127,604,317 | 0.55% | 0.02% |
| Feb. 18, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 4514 | $0.00 | 0.0000 | 127,604,317 | 100.00% | 0.00% |
| Feb. 18, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 4514 | $0.00 | 5,361,166.0000 | 127,604,317 | 0.08% | 0.00% |
| Feb. 18, 2026 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1339 | $4.20 | 5,359,827.0000 | 127,604,317 | 0.02% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,321,175.0000 | 127,604,317 | 0.13% | 0.01% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 2660 | $5.53 | 5,318,515.0000 | 127,604,317 | 0.05% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 11781 | $0.00 | 5,330,296.0000 | 127,604,317 | 0.22% | 0.01% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 4636 | $5.53 | 5,325,660.0000 | 127,604,317 | 0.09% | 0.00% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 22100 | $0.00 | 5,347,760.0000 | 127,604,317 | 0.41% | 0.02% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 8697 | $5.53 | 5,339,063.0000 | 127,604,317 | 0.16% | 0.01% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 29002 | $0.00 | 5,368,065.0000 | 127,604,317 | 0.54% | 0.02% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 11413 | $5.53 | 5,356,652.0000 | 127,604,317 | 0.21% | 0.01% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 4,514.0000 | 127,604,317 | 59.95% | 0.01% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 29002 | $0.00 | 386,699.0000 | 127,604,317 | 6.98% | 0.02% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 22100 | $0.00 | 206,273.0000 | 127,604,317 | 9.68% | 0.02% |
| Nov. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 11781 | $0.00 | 62,837.0000 | 127,604,317 | 15.79% | 0.01% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1646 | $4.06 | 5,266,847.0000 | 130,611,330 | 0.03% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 11781 | $0.00 | 74,618.0000 | 130,611,330 | 13.64% | 0.01% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 22100 | $0.00 | 228,373.0000 | 130,611,330 | 8.82% | 0.02% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 29002 | $0.00 | 415,701.0000 | 130,611,330 | 6.52% | 0.02% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 11,272.0000 | 130,611,330 | 37.48% | 0.01% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 7062 | $4.06 | 5,314,417.0000 | 130,611,330 | 0.13% | 0.01% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 29002 | $0.00 | 5,321,479.0000 | 130,611,330 | 0.55% | 0.02% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,268,493.0000 | 130,611,330 | 0.13% | 0.01% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 5382 | $4.06 | 5,292,477.0000 | 130,611,330 | 0.10% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 22100 | $0.00 | 5,297,859.0000 | 130,611,330 | 0.42% | 0.02% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 2869 | $4.06 | 5,275,759.0000 | 130,611,330 | 0.05% | 0.00% |
| Aug. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 11781 | $0.00 | 5,278,628.0000 | 130,611,330 | 0.22% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 14733 | $0.00 | 5,250,697.0000 | 130,611,330 | 0.28% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 14733 | $0.00 | 250,473.0000 | 130,611,330 | 5.56% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 7854 | $0.00 | 86,399.0000 | 130,611,330 | 8.33% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 18,030.0000 | 130,611,330 | 27.26% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 4708 | $2.69 | 5,261,735.0000 | 130,611,330 | 0.09% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 19334 | $0.00 | 5,266,443.0000 | 130,611,330 | 0.37% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 3588 | $2.69 | 5,247,109.0000 | 130,611,330 | 0.07% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1913 | $2.69 | 5,235,964.0000 | 130,611,330 | 0.04% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 7854 | $0.00 | 5,237,877.0000 | 130,611,330 | 0.15% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1646 | $2.69 | 5,230,023.0000 | 130,611,330 | 0.03% | 0.00% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,231,669.0000 | 130,611,330 | 0.13% | 0.01% |
| May 19, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 19334 | $0.00 | 444,703.0000 | 130,611,330 | 4.17% | 0.01% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 4658 | $4.36 | 5,203,442.0000 | 130,611,330 | 0.09% | 0.00% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 29467 | $0.00 | 265,206.0000 | 130,611,330 | 10.00% | 0.02% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 7998 | $4.36 | 5,224,911.0000 | 130,611,330 | 0.15% | 0.01% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 15708 | $0.00 | 5,208,100.0000 | 130,611,330 | 0.30% | 0.01% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 29467 | $0.00 | 5,232,909.0000 | 130,611,330 | 0.57% | 0.02% |
| March 10, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 15708 | $0.00 | 94,253.0000 | 130,611,330 | 14.29% | 0.01% |
| March 4, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | A | Restricted Stock Units | 464037 | $0.00 | 464,037.0000 | 130,611,330 | 9999.99% | 0.36% |
| March 4, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 735294 | $0.00 | 735,294.0000 | 130,611,330 | 9999.99% | 0.56% |
| Feb. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 2004 | $5.31 | 5,192,392.0000 | 130,611,330 | 0.04% | 0.00% |
| Feb. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,194,396.0000 | 130,611,330 | 0.13% | 0.01% |
| Feb. 18, 2025 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 24,788.0000 | 130,611,330 | 21.42% | 0.01% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 22100 | $0.00 | 5,193,020.0000 | 132,785,552 | 0.43% | 0.02% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 31,546.0000 | 132,785,552 | 17.64% | 0.01% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 11781 | $0.00 | 109,961.0000 | 132,785,552 | 9.68% | 0.01% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 22100 | $0.00 | 294,673.0000 | 132,785,552 | 6.98% | 0.02% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 5382 | $6.03 | 5,187,638.0000 | 132,785,552 | 0.10% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 2869 | $6.03 | 5,170,920.0000 | 132,785,552 | 0.06% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 11781 | $0.00 | 5,173,789.0000 | 132,785,552 | 0.23% | 0.01% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1646 | $6.03 | 5,162,008.0000 | 132,785,552 | 0.03% | 0.00% |
| Nov. 18, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,163,654.0000 | 132,785,552 | 0.13% | 0.01% |
| Sept. 14, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | G | Common Stock | 200000 | $0.00 | 5,156,896.0000 | 135,283,044 | 3.73% | 0.15% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 5382 | $5.53 | 5,356,896.0000 | 135,283,044 | 0.10% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,332,912.0000 | 135,283,044 | 0.13% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1646 | $5.53 | 5,331,266.0000 | 135,283,044 | 0.03% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 11781 | $0.00 | 5,343,047.0000 | 135,283,044 | 0.22% | 0.01% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 2869 | $5.53 | 5,340,178.0000 | 135,283,044 | 0.05% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 22100 | $0.00 | 5,362,278.0000 | 135,283,044 | 0.41% | 0.02% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 38,304.0000 | 135,283,044 | 15.00% | 0.00% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 11781 | $0.00 | 121,742.0000 | 135,283,044 | 8.82% | 0.01% |
| Aug. 19, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 22100 | $0.00 | 316,773.0000 | 135,283,044 | 6.52% | 0.02% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 14733 | $0.00 | 338,873.0000 | 135,283,044 | 4.17% | 0.01% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,310,669.0000 | 135,283,044 | 0.13% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1601 | $5.96 | 5,309,068.0000 | 135,283,044 | 0.03% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 7854 | $0.00 | 5,316,922.0000 | 135,283,044 | 0.15% | 0.01% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 1913 | $5.96 | 5,315,009.0000 | 135,283,044 | 0.04% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 14733 | $0.00 | 5,329,742.0000 | 135,283,044 | 0.28% | 0.01% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 3588 | $5.96 | 5,326,154.0000 | 135,283,044 | 0.07% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 45,062.0000 | 135,283,044 | 13.04% | 0.00% |
| May 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 7854 | $0.00 | 133,523.0000 | 135,283,044 | 5.56% | 0.01% |
| March 11, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 15708 | $0.00 | 5,308,557.0000 | 135,283,044 | 0.30% | 0.01% |
| March 11, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 4646 | $7.22 | 5,303,911.0000 | 135,283,044 | 0.09% | 0.00% |
| March 11, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 15708 | $0.00 | 141,377.0000 | 135,283,044 | 10.00% | 0.01% |
| March 6, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 526315 | $0.00 | 526,315.0000 | 135,283,044 | 9999.99% | 0.39% |
| March 6, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | A | Restricted Stock Units | 353606 | $0.00 | 353,606.0000 | 135,283,044 | 9999.99% | 0.26% |
| Feb. 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Restricted Stock Units | 6758 | $0.00 | 51,820.0000 | 135,283,044 | 11.54% | 0.00% |
| Feb. 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | M | Common Stock | 6758 | $0.00 | 5,294,853.0000 | 135,283,044 | 0.13% | 0.00% |
| Feb. 20, 2024 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | PRESIDENT AND CEO | F | Common Stock | 2004 | $8.38 | 5,292,849.0000 | 135,283,044 | 0.04% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 3965 | $5.98 | 5,288,095.0000 | 138,562,111 | 0.07% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 6758 | $0.00 | 5,282,554.0000 | 138,562,111 | 0.13% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 2275 | $5.98 | 5,280,279.0000 | 138,562,111 | 0.04% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 11781 | $0.00 | 5,292,060.0000 | 138,562,111 | 0.22% | 0.01% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 6758 | $0.00 | 58,578.0000 | 138,562,111 | 10.34% | 0.00% |
| Nov. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 11781 | $0.00 | 157,085.0000 | 138,562,111 | 6.98% | 0.01% |
| Nov. 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $4.34 | 5,275,796.0000 | 138,562,111 | 0.38% | 0.01% |
| Oct. 9, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $5.33 | 5,295,796.0000 | 138,562,111 | 0.38% | 0.01% |
| Sept. 14, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | G | Common Stock | 2290000 | $0.00 | 5,315,796.0000 | 138,562,111 | 30.11% | 1.65% |
| Sept. 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $6.83 | 7,605,796.0000 | 138,562,111 | 0.26% | 0.01% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 3965 | $8.46 | 7,625,796.0000 | 138,562,111 | 0.05% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 11781 | $0.00 | 168,866.0000 | 138,562,111 | 6.52% | 0.01% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 2245 | $8.46 | 7,617,980.0000 | 138,562,111 | 0.03% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 11781 | $0.00 | 7,629,761.0000 | 138,562,111 | 0.15% | 0.01% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 6758 | $0.00 | 65,336.0000 | 138,562,111 | 9.37% | 0.00% |
| Aug. 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 6758 | $0.00 | 7,620,225.0000 | 138,562,111 | 0.09% | 0.00% |
| Aug. 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $9.04 | 7,613,467.0000 | 138,562,111 | 0.26% | 0.01% |
| July 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $8.48 | 7,633,467.0000 | 138,562,111 | 0.26% | 0.01% |
| June 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $8.23 | 7,653,467.0000 | 138,562,111 | 0.26% | 0.01% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 2633 | $6.69 | 7,668,564.0000 | 138,562,111 | 0.03% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 7854 | $0.00 | 7,676,418.0000 | 138,562,111 | 0.10% | 0.01% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 2951 | $6.69 | 7,673,467.0000 | 138,562,111 | 0.04% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 6758 | $0.00 | 72,094.0000 | 138,562,111 | 8.57% | 0.00% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 7854 | $0.00 | 180,647.0000 | 138,562,111 | 4.17% | 0.01% |
| May 18, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 6758 | $0.00 | 7,671,197.0000 | 138,562,111 | 0.09% | 0.00% |
| May 8, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $11.55 | 7,664,439.0000 | 138,562,111 | 0.26% | 0.01% |
| April 10, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $8.88 | 7,684,439.0000 | 138,562,111 | 0.26% | 0.01% |
| March 3, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | A | Restricted Stock Units | 188501 | $0.00 | 188,501.0000 | 138,562,111 | 9999.99% | 0.14% |
| March 3, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | A | Employee Stock Option (Right to Buy) | 284900 | $0.00 | 284,900.0000 | 138,562,111 | 9999.99% | 0.21% |
| March 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $10.13 | 7,704,439.0000 | 138,562,111 | 0.26% | 0.01% |
| Feb. 21, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Restricted Stock Units | 6758 | $0.00 | 78,852.0000 | 138,562,111 | 7.89% | 0.00% |
| Feb. 21, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | F | Common Stock | 2633 | $10.97 | 7,724,439.0000 | 138,562,111 | 0.03% | 0.00% |
| Feb. 21, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | M | Common Stock | 6758 | $0.00 | 7,727,072.0000 | 138,562,111 | 0.09% | 0.00% |
| Feb. 7, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $13.19 | 7,720,314.0000 | 138,562,111 | 0.26% | 0.01% |
| Jan. 9, 2023 | Cytek Biosciences, Inc. | $CTKB | Jiang Wenbin | President and CEO | S | Common Stock | 20000 | $10.66 | 7,740,314.0000 | 138,562,111 | 0.26% | 0.01% |